Healthcare Services Group, Inc. HCSG
25.57 USD -0.19 (-0.74%)
At closeNov 3, 2026, 4:06 PM EST
25.57 0.00 0.00%
After hours · Nov 3, 4:06 PM ET
25.05 Day range 26.28
16.78 52-week range 26.28
- YTD
- +33.73%
- 1 year
- +43.01%
Analyst view
Consensus: buy
Buy
Price target (mean) 26.67 +4.3% upside
Now 25.57
- Target (low)
- 24.00
- Target (mean)
- 26.67
- Target (high)
- 30.00
Ratings (0m) 7 4 buy · 3 hold · 0 sell
- Strong buy0
- Buy4
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.27127 | 0.24 – 0.30 | 0.44 | -38.3% | 537.85M | +15.3% | 7 |
| Next quarter | 0.295 | 0.26 – 0.31 | 0.37 | -20.3% | 533.20M | +15.2% | 4 |
| Current year | 1.34 | 1.29 – 1.46 | 0.81 | +65.1% | 1.95B | +6.2% | 7 |
| Next year | 1.25 | 1.09 – 1.37 | 1.34 | -6.2% | 2.18B | +11.7% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 8, 2026 | Baird | Maintained | Neutral | Neutral |
| Aug 19, 2026 | Oppenheimer | Initiated | — | Outperform |
| Jul 8, 2026 | UBS | Maintained | Buy | Buy |
| Apr 23, 2026 | UBS | Maintained | Buy | Buy |
| Apr 23, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Apr 23, 2026 | Benchmark | Maintained | Buy | Buy |
| Apr 23, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Mar 3, 2026 | RBC Capital | Initiated | — | Sector Perform |
| Nov 13, 2025 | BMO Capital | Initiated | — | Market Perform |
| Oct 28, 2025 | UBS | Maintained | Buy | Buy |
| Oct 23, 2025 | Benchmark | Maintained | Buy | Buy |
| Jul 29, 2025 | Macquarie | Upgrade | Neutral | Outperform |
| Jul 24, 2025 | Benchmark | Maintained | Buy | Buy |
| Jul 24, 2025 | Baird | Maintained | Neutral | Neutral |
| Apr 28, 2025 | Macquarie | Maintained | Neutral | Neutral |
| Apr 24, 2025 | Baird | Maintained | Neutral | Neutral |
| Apr 24, 2025 | UBS | Upgrade | Neutral | Buy |
| Dec 19, 2024 | Benchmark | Reiterated | Buy | Buy |
| Dec 16, 2024 | Macquarie | Initiated | — | Neutral |
| Oct 24, 2024 | Benchmark | Reiterated | Buy | Buy |
| Oct 24, 2024 | Baird | Maintained | Neutral | Neutral |
| Jul 25, 2024 | Benchmark | Reiterated | Buy | Buy |
| Jul 25, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 25, 2024 | Baird | Maintained | Neutral | Neutral |
| Feb 15, 2024 | Benchmark | Maintained | Buy | Buy |
| Feb 15, 2024 | UBS | Maintained | Neutral | Neutral |
| Feb 15, 2024 | Baird | Maintained | Neutral | Neutral |
| Feb 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 22, 2023 | Benchmark | Reiterated | Buy | Buy |
| Nov 30, 2023 | UBS | Initiated | — | Neutral |